Modalis Therapeutics Announces Executive Reshuffle
Company Announcements

Modalis Therapeutics Announces Executive Reshuffle

Modalis Therapeutics Corporation (JP:4883) has released an update.

Modalis Therapeutics Corporation announces a new executive appointment with Yosuke Nakashima stepping up as VP of Operations and Business Development, after serving as Director of Business Development and US Site Controller.

For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App